FOXO TECHNOLOGIES INC.

FOXO

{{popupValue}}
{{popupSubtitle}}

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker
FOXO
CIK0001812360
SIC8731
SectorServices
Industry CategoryBusiness Services
Industry GroupServices – Research, Development, Testing Labs

Contact

Address729 WASHINGTON AVE. N, SUITE 600, MINNEAPOLIS, MN, 55401
Website foxotechnologies.com
Phone(612) 562-9447
CEOTyler Danielson
Employees3

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement
Revenue$14.76 million
Pre-Tax Income$-9.83 million
Net Income$-7.35 million
Net Income to Common$-23.79 million
EPS$10.50
View All
Balance Sheet
Cash$628,557.00
Assets$52.09 million
Liabilities$31.96 million
Common Equity$20.20 million
Liabilities & Equity$52.09 million
View All
Cash Flow Statement
Calculations
NOPAT$-4.08 million
EBITDA$-3.53 million
Price to EarningsN/A
Price to Book$0.00
ROE-569.68%
View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

FOXO Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities

WEST PALM BEACH, FL, Jan. 20, 2026 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “Company”) today announced that its critical access-designated acute care hospital, Scott County Community Hospital, Inc. (d/b/a Big South Fork Medical Center), has expanded its clinical capabilities through the addition of inpatient tele-specialty services and cardiac diagnostics. In partnership with Rural Physicians Group, Big South Fork Medical Center now provides inpatient tele-specialty

Article Link

FOXO TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES YEAR-END REVIEW TO SHAREHOLDERS

WEST PALM BEACH, FL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces Chief Executive Officer Seamus Lagan has provided the following Year-End Review to shareholders: FOXO Shareholders: As we rapidly approach year-end, I wanted to reach out to our shareholders to review key milestones of 2025 and preview our go-forward operating and growth strategy. Much of the foundation of the “new” FOXO was created in mid-2024 when the Company acquired both Myrtl

Article Link

FOXO Technologies Inc. Subsidiary, Myrtle Recovery Centers, Recognized by the Rural Health Association of Tennessee for Outstanding Community Impact

WEST PALM BEACH, FL, Dec. 09, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (“FOXO” or the “Company”) today announced that its behavioral health subsidiary, Myrtle Recovery Centers, Inc., was recently recognized by the Rural Health Association of Tennessee (“RHA”) at their Awards Luncheon during the Annual RHA Conference. RHA celebrated Myrtle’s ongoing engagement, willingness to share lessons learned, and its service to communities across Tennessee. The recognition comes after Myr

Article Link

FOXO TECHNOLOGIES INC. ANNOUNCES CLOSING OF VECTOR BIOSOURCE INC. ACQUISITION

WEST PALM BEACH, FL, Sept. 22, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTCID: FOXO) (“FOXO” or the “Company”), announces the closing of the acquisition of Vector Biosource Inc. (“Vector”). Vector is an information, data and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries. Vector generated second quarter 2025 net revenues of approximately $225,000 ($0.9 million on an annual run rate basis) and is expected to grow significa

Article Link

FOXO TECHNOLOGIES INC. ANNOUNCES ACQUISITION AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.

WEST PALM BEACH, FL, Sept. 11, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (OTC: FOXO) (the “Company”), announces that it has signed a stock purchase agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information, data and biospecimen sourcing provider serving the biotechnology, clinical research and pharmaceutical research industries. Vector generated second quarter 2025 net revenues of approximately $225,000 ($0.9 million on an annual run rate basis) and is expected to gro

Article Link